Mylan to invest in Andhra PradeshIllustrative image – not actual.

US-based pharmaceutical major Mylan is considering to invest USD 5 billion (Rs 31,000 crore) in Andhra Pradesh.


A delegation of the US-India Business Council (USIBC) met Andhra Chief Minister Chandrababu Naidu on 20 April 2015.


During the meeting Naidu said that he wants to see Andhra Pradesh as a healthcare hub with health and education being government's priorities.


Mylan already operates four active pharmaceutical ingredient (API) manufacturing facilities in the Vizag region — Unit eight at Poosapatirega mandal in Vizianagaram, Unit nine and 12 at Jawaharlal Nehru Pharma City and Unit 10 at Parawada.


Since its foray into India in 2007, Mylan has set up nine APIs, four finished dosage formulations (FDF) and eight injectable manufacturing units spread across the states of Telangana, Andhra Pradesh, Maharashtra, Madhya Pradesh, Karnataka and Tamil Nadu

← All latest storiesBack to top →